As of August 28, 2026, RxSight, Inc. (RXST) has a DilutionWatch DilutionScore of 27/100, rated MEDIUM dilution risk. RxSight, Inc. has a market capitalization of $220.64M, 41.59M shares outstanding, 164 institutional holders tracked.
This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.
Dilution Forecast
☀️
Clear
No significant dilution signals
model est. 0%
No significant dilution signals detected for RXST.
Market Data
Market Cap$220.64M
Shares Outstanding41.59M
Float39.18M
Cash$208.80M
DebtN/A
Short InterestN/A
Institutional Holdings
QoQ: ↑ 15.1% shares (2026Q1 vs prior)
164 institutional holders · 43.25M shares
#1
VANGUARD CAPITAL MANAGEMENT LLC
3.39M shares
#2
BlackRock, Inc.
3.19M shares
#3
MORGAN STANLEY
2.22M shares
Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.
Short Interest
Short Interest4.06M
Days to Cover4.0
% of Float10.3%
FINRA data as of Jul 31, 2026
Recent SEC Activity
xbrl
XBRL CONVERTIBLE
2021-09-30
Full SEC filing analysis available with free account
→
Recent News
No recent news
Factual RXST Dilution Snapshot
RxSight, Inc. (RXST) has a DilutionScore of 27/100, rated Medium dilution risk. Score date: August 28, 2026.
- Recent SEC activity tracked for RXST: xbrl on 2021-09-30.
This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.
Track RXST Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking RXST — Free
Real-time SEC alerts
DilutionScore™ tracking
No credit card required
More Research for RXST
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.